Source-grounded facts extracted from United Health Products, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
United Health Products, Inc. entered into Any Market Purchase Agreement with Alumni Capital LP valued at up to an aggregate of $4,000,000 (effective 2025-12-16).
“On December 16, 2025, the Company entered into an Any Market Purchase Agreement ("AMPA") with Alumni, whereby the Company has the right, but not the obligation, to sell to Alumni, and Alumni is obligated to purchase, up to an aggregate of $4,000,000 (the "Commitment Amount") of shares of the Company's common stock (the "Shares"), in a series of purchases.”
Material Agreements
United Health Products, Inc. entered into Securities Purchase Agreement with Alumni Capital LP valued at $289,821 (effective 2025-12-16).
“On December 16, 2025, United Health Products, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Alumni Capital LP, a Delaware limited partnership ("Alumni"), pursuant to which Alumni made a loan to the Company, evidenced by a senior convertible promissory note in the principal amount of $289,821 (the "Note").”
Debt Financings
United Health Products, Inc. incurred convertible notes of $289,821 with Alumni Capital LP at 15% per annum maturing December 31, 2026.
“On December 16, 2025, United Health Products, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Alumni Capital LP, a Delaware limited partnership (“Alumni”), pursuant to which Alumni made a loan to the Company, evidenced by a senior convertible promissory note in the principal amount of $289,821 (the “Note”).”
Brian Thom was appointed as interim principal financial officer at United Health Products, Inc..
“In the interim, United Health Products’ Chief Executive Officer, Brian Thom, will act as the Company’s principal financial officer.”
Kristofer Heaton resigned as Vice President of Finance and Principal Financial Officer at United Health Products, Inc..
“Kristofer Heaton resigned from the positions of Vice President of Finance and Principal Financial Officer of United Health Products effective on June 12, 2025, citing consideration of personal and professional factors.”
Material Agreements
United Health Products, Inc. amended Common Stock Purchase Agreement dated September 1, 2022 with White Lion Capital, LLC (effective 2023-01-25).
“On January 25, 2023, the Company and White Lion amended the CSPA to provide that if the Company issues a share price purchase notice at a time that the Company’s common stock is trading below the Floor Price and White Lion waives the Floor Price condition, the share purchase price multiplier for that transaction will be 90% instead of 93%.”
Louis Schiliro resigned as director and Chief Operating Officer at United Health Products, Inc..
“Louis Schiliro submitted his resignation as a director and Chief Operating Officer of the Company, each effective on February 28, 2022”
Douglas Beplate resigned as director at United Health Products, Inc..
“On February 18, 2022 Douglas Beplate submitted his resignation as a director of United Health Products, Inc.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.